VirION EU-MSCA Doctoral Network
VirION is a European Marie Skłodowska-Curie Doctoral Network focused on understanding how cellular organelles, particularly peroxisomes, influence viral infection and antiviral immunity. By combining expertise in virology, organelle biology, systems biology, and innovation, the programme will equip 15 Doctoral Candidates (DCs) with the skills needed to develop novel host-directed antiviral strategies and address emerging viral threats.
The network unites 10 academic institutions, 3 academic medical centers, 1 research institute, and 6 industrial partners, providing a comprehensive research and innovation environment. The DCs will be hired by the network’s participating entities to contribute to VirION's overarching scientific objectives while pursuing individual research projects focused on specific biological models, viruses, methodologies, or technologies. Their training blends academic research with interdisciplinary training schools, advanced courses, transferable-skills development, and conference attendance, complemented by secondments across sectors, disciplines, research groups, and countries. In parallel, each DC will follow a personalized career development plan and work towards obtaining a PhD degree.
PhD project
Hereby, Amsterdam UMC is offering the DC10 position (out of the 15 available DC positions within VirION) entitled Validating the roles of peroxisomes in viral infection in human iPSCs and iPSC-derived lung and liver-like models.
You will be employed by Amsterdam UMC and work within the Human Model Systems research environment and the Amsterdam UMC iPSC core facility, supervised by Prof. dr. Vivi Heine, with co-supervision by Dr Nicolas Locker (The Pirbright Institute). The anticipated PhD degree will be awarded by Vrije Universiteit Amsterdam (VUA).
Doctoral project DC10 will develop physiologically relevant human iPSC-derived models to validate how peroxisomal metabolism and dynamics influence viral infection. You will differentiate male and female human iPSCs into lung- and liver-like models and investigate virus-peroxisome interactions in these systems. Using CRISPR-Cas9, targeted gene deletions in key peroxisomal pathways will be introduced and their effects on viral infection and antiviral drug responses assessed. The project combines human stem cell biology, cell biology and virology, and includes international training in peroxisomal assays, viral infection techniques and organ-on-chip technology through planned secondments.
For more details please check VirION’s webpage: Home | VirION
Please read more information about the Marie Sklodowska-Curie Doctoral Network (MSCA-DN) projects here.
Would you like to know more about the different phases within the PhD trajectory? You can read more about this on this page.
As a doctoral candidate, you will develop and apply human iPSC-based lung- and liver-like models to investigate the role of peroxisomes in viral infection. Your research and tasks will include:
The project is expected to generate robust human iPSC-derived lung- and liver-like models and provide insight into how peroxisomal functions affect viral infection and antiviral drug responses. It will also validate key findings from other VirION projects in more physiologically relevant human models and assess potential sex-specific effects.
VirION offers an international and interdisciplinary research environment and an extensive doctoral training programme providing ample opportunities to further develop your scientific and transferable skills.
For this position, we are looking for a curious, highly motivated, and collaborative PhD candidate with a strong interest in human induced pluripotent stem cell (iPSC) biology, advanced human cell models, and virus-host interactions. You hold a Master's degree or equivalent in biomedical sciences, molecular/cell biology, biotechnology, developmental biology, neuroscience, life sciences, or a related discipline.
You bring:
Eligibility criteria
Amsterdam UMC welcomes applications from all interested candidates who meet the position's requirements, irrespective of age, gender, race, disability, religion, or ethnic background.
In addition, prospective Doctoral Candidates must comply with the strict eligibility criteria of the Marie Skłodowska-Curie Actions:
Non-EU/EEA/Swiss applicants require a valid residence permit to live and work in the Netherlands.
You will work at Amsterdam UMC in the Human Model Systems research environment and the Amsterdam UMC iPSC core facility. Amsterdam UMC is one of the largest institutions for health research and patient care in the Netherlands and offers high-quality core facilities relevant to this project, including Induced Pluripotent Stem Cells, the CRISPR Expertise Center, Genomics, Metabolomics, Microscopy and Cytometry, and the Research Imaging Core Center.
Amsterdam UMC encourages Open Science, endorses the principles of the European Charter for Researchers, and hosts an active Doctoral School, where PhD candidates benefit from supervision training and a lively peer network.
You will be supervised by Prof. dr. Vivi Heine, Professor of Human Model Systems, group leader and head of the Amsterdam UMC iPSC core facility. Her expertise is in patient and human iPSC modelling, including 2D and 3D human stem-cell technologies and iPSC-based disease models. She is also chair of the hDMT Consortium Assembly (Dutch Organ-on-Chip consortium). Dr Nicolas Locker from The Pirbright Institute will co-supervise the project and contribute expertise in viral infection and virus-host responses.
In addition, you will join the international VirION doctoral network, where you will collaborate with researchers from different scientific disciplines and with academic and industrial partners throughout Europe. Secondments, network-wide training, and transferable-skills development will allow you to broaden your experience beyond your own research project and to build a professional network spanning multiple countries and sectors.
The first-round interviews are expected to take place in December 2026. A possible second interview round will follow in December 2026 or January 2027. Shortlisted candidates will receive the exact dates in advance.
If you have questions about this PhD position that are not covered by the vacancy or accompanying documents, please contact Prof. dr. Vivi Heine, Principal Investigator, via vm.heine@amsterdamumc.nl.
How to apply:
The application deadline is 16 December 2026. We aim to select the final candidate in December 2026/January 2027.
Applications are online and must be submitted in English. The recruitment for the DC vacancy herein offered is handled locally by Amsterdam UMC, responsible for receiving, checking, shortlisting and hiring a researcher for this vacancy.
The following application documents are mandatory to apply:
Selection of DC candidate
Applicants may, where appropriate and in line with the recruitment procedure, also be considered for other VirION DC positions that better match their profile and interests. You can highlight up to two additional DC projects of interest in your application letter. This does not replace your application to the primary position, but helps the consortium identify potential alternative matches where relevant. For information on the other DC positions please check VirION’s webpage: Home | VirION.


